布罗克辛在帕金森病中的作用。一种外周和中枢脱羧酶抑制剂增强左旋多巴的作用。
Brocresine in Parkinson's disease. Action of a peripheral and central decarboxylase inhibitor in potentiating levodopa.
作者信息
Howse P M, Matthews W B
出版信息
J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):27-9. doi: 10.1136/jnnp.36.1.27.
Abstract
Brocresine, an aromatic L-amino acid decarboxylase inhibitor with both a peripheral and central action was shown to potentiate the therapeutic effect of levodopa in Parkinson's disease. The search for useful decarboxylase inhibitors therefore need not be limited to agents that do not pass the blood/brain barrier.
摘要
溴克辛是一种具有外周和中枢作用的芳香族L-氨基酸脱羧酶抑制剂，已证明它能增强左旋多巴对帕金森病的治疗效果。因此，寻找有用的脱羧酶抑制剂不必局限于不能通过血脑屏障的药物。
相似文献
1
Brocresine in Parkinson's disease. Action of a peripheral and central decarboxylase inhibitor in potentiating levodopa.布罗克辛在帕金森病中的作用。一种外周和中枢脱羧酶抑制剂增强左旋多巴的作用。
J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):27-9. doi: 10.1136/jnnp.36.1.27.
2
[Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].[左旋多巴与脱羧酶抑制剂（Ro 4-4602）治疗帕金森综合征。71例患者的病程]
Schweiz Med Wochenschr. 1972 Jan 22;102(3):88-94.
3
4
[Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].[联合用药（左旋多巴加脱羧酶抑制剂（Ro 8-0576））治疗帕金森病的经验]
Wien Med Wochenschr. 1973 Jun 30;123(26):433-5.
5
Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.用左旋多巴和脱羧酶抑制剂治疗帕金森病。
Z Neurol. 1972;202(1):1-20. doi: 10.1007/BF00316422.
6
[Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].
Dtsch Med Wochenschr. 1969 Dec 26;94(52):2678-81. doi: 10.1055/s-0028-1110503.
7
Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa.用外周脱羧酶抑制剂卡比多巴和左旋多巴治疗帕金森病。
Med Ann Dist Columbia. 1974 Dec;43(12):587-91.
8
[Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa?].
Presse Med (1893). 1971 Jan 16;79(3):91-2.
9
Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase.左旋多巴联合脑外多巴脱羧酶抑制剂L-α-甲基多巴肼治疗帕金森病。
J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):10-4. doi: 10.1136/jnnp.36.1.10.
10
[Therapeutic association of L-dopa and an inhibitor of peripheral decarboxylase in Parkinsonism. Preliminary results].
Acta Neurol (Napoli). 1973 Mar-Apr;28(2):208-12.
引用本文的文献
1
Ophthalmate is a new regulator of motor functions via CaSR: implications for movement disorders.眼氨酸通过钙敏感受体调节运动功能：对运动障碍的影响。
Brain. 2024 Oct 3;147(10):3379-3394. doi: 10.1093/brain/awae097.
本文引用的文献
1
EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO.
Int J Neuropharmacol. 1964 May;3:177-88. doi: 10.1016/0028-3908(64)90006-1.
2
A fluorimetric method for the determination of dopamine (3-hydroxytyramine).一种测定多巴胺（3-羟基酪胺）的荧光分析法。
Acta Physiol Scand. 1958 Dec 15;44(3-4):293-8. doi: 10.1111/j.1748-1716.1958.tb01628.x.
3
A method for the fluorimetric determination of adrenaline and noradrenaline in tissues.一种用于荧光测定组织中肾上腺素和去甲肾上腺素的方法。
Acta Physiol Scand. 1958 Dec 15;44(3-4):273-92. doi: 10.1111/j.1748-1716.1958.tb01627.x.
4
Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.外周脱羧酶选择性抑制后C14 - 多巴的脑内蓄积与代谢
J Pharmacol Exp Ther. 1968 May;161(1):14-20.
5
[Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].[左旋多巴联合脱羧酶抑制剂治疗帕金森综合征。II]
Rev Neurol (Paris). 1970 Nov;123(5):297-319.
6
[Two years experience with L-DOPA in association with a decarboxylase inhibitor].左旋多巴与脱羧酶抑制剂联合应用两年的经验
Rev Neurol (Paris). 1970 Apr;122(4):243-8.
7
Assay and rapid disappearance of brocresine activity in blood.血液中布罗克瑞辛活性的测定及快速消失
Biochem Pharmacol. 1971 Jul;20(7):1501-6.
Zotero 插件